Biogen Inc. (BIIB) Net earnings per share (EPS TTM)
Biogen Inc. revenue is based on the sale of advanced treatments for Alzheimer's and multiple sclerosis. The trailing 12-month earnings per share visualizes the financial dynamics, where 2.32 reflects the latest value of the metric. Its status as a neuromedicine leader confirms the brand's authority, while the stable operation of biopharmaceutical plants guarantees strict adherence to technological production regulations.
Metric breakdowns and analytics for Biogen Inc (BIIB)
- stock price and consensus target price:
- market capitalization details:
- business book valuation details:
- debt and liquidity details:
- earnings and multiples data:
BIIB - Company Net Income|Projected Future Earnings Biogen Inc.|BIIB - Business Payback Period|Forward P/E Multiple Biogen|BIIB - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Biogen Inc.|BIIB - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Biogen|BIIB - Earnings per share for the last 12 months|Quarterly EPS earnings growth biogen.com|BIIB - Earnings per share growth rate in current year|Expected earnings per share growth for next year Biogen Inc.
Fundamental valuation:Biogen Inc. (BIIB)
A fundamental stress test of positions requires an analysis of net income allocated per share, which allows for an assessment of real capital generation efficiency without accounting for equity dilution. Since demand for Biogen Inc. (BIIB) drugs is inelastic and independent of macroeconomic factors, the company's EPS TTM trend serves as an objective indicator of business resilience amid fierce competition in the gene therapy sector.
Competitor analysis
Neurocrine Biosciences - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year regencellbioscience.com (RGC)|AXSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ACADIA Pharma (ACAD)|Earnings per share for the last twelve months Xenon Pharmaceuticals Inc|Earnings per share for the last 12 months VKTX (Viking Therapeutics Corp)|Net earnings per share for the last 12 months SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) DNLI (Denali Therapeutics Inc.)|Net earnings per share for the last four quarters Harmony Biosciences Inc (HRMY)|BHVN - Earnings per share for the last twelve months|AMLX (Amylyx Corp) - Earnings per share for the last 12 months|TRVI: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months praxismedicines.com|Net earnings per share for the last 12 months AVXL|CeriBell Inc (CBLL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) PRTA|Earnings per share for the last twelve months ALEC (alector.com)|Net earnings per share (EPS TTM) ANNX (Annexon, Inc.)|Net earnings per share for the last four quarters Omeros Corp (OMER)|Neurogene - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters AC Immune S.A. ACIU|VYGR: Net earnings per share (EPS TTM)|NMRA (Neumora Corp) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Scilex Holding Company|Earnings per share for the last 12 months TVGN (tevogen.com)|Net earnings per share (EPS TTM) ACOG|CGTX - Net earnings per one share for the last twelve months|Inhibikase - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Cassava Pharma SAVA|ASRT - Earnings per share for the last twelve months|Earnings per share for the trailing year COYA (Coya Therapeutics, Inc.)|vistagen.com (VTGN) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Ovid Therapeutics (OVID)|ABOS (Acumen Pharma) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months CRVO|Net earnings per share (EPS TTM) ATHE|Net earnings per share for the last four quarters clene.com|Earnings per share for the last twelve months PepGen PEPG|Jupiter Neurosciences, Inc. (JUNS) - Net earnings per one share for the last twelve months|Relmada - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Annovis Bio Corporation (ANVS)|GRCE: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months fireflyneuro.com (AIFF)|Earnings per share for the last twelve months ANEW Medical|Earnings per share for the last 12 months NRSN (NeuroSense Therapeutics, Ltd.)|Net earnings per share for the last 12 months RVPH (Reviva Pharmaceuticals Holdings)|MTVA (metaviatx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRXS (NeurAxis, Inc.)|Net earnings per share for the last four quarters Helius Medical Technologies, Inc. (HSDT)|PASG - Earnings per share for the last twelve months|NEUP (Neuphoria Therapeutics Inc.) - Earnings per share for the last 12 months|NERV: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Athira Pharma Corp|Net earnings per share for the last 12 months ADXN|Alzamend (ALZN) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) CYCN|Earnings per share for the last twelve months PTIX (protagenic.com)|Net earnings per share (EPS TTM) KTTA (Pasithea Therapeutics Corp.)|Net earnings per share for the last four quarters Cortigent Inc (CRGT)|Avenue Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters brainstorm-cell.com BCLI|CARA: Net earnings per share (EPS TTM)|CHRO (Chromocell Therapeutics Corp) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Eliem Therapeutics, Inc.|Earnings per share for the last 12 months ITCI (Intra-Cellular)|Net earnings per share (EPS TTM) LBPH|MRNS - Net earnings per one share for the last twelve months|NKGen Biotech - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) NeuroBo Pharmaceuticals Inc NRBO|SAGE - Earnings per share for the last twelve months|Earnings per share for the trailing year SNPX (Synaptogenix, Inc)|Trevena, Inc. (TRVN) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Vigil Neuroscience, Inc. (VIGL)|WENA (Anew Medical) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months CERE
